<DOC>
	<DOCNO>NCT03010397</DOCNO>
	<brief_summary>Progression Diabetic Retinopathy . Identification Signs Surrogate outcome ( PROGRESS )</brief_summary>
	<brief_title>Progression Diabetic Retinopathy . Identification Signs Surrogate Outcomes</brief_title>
	<detailed_description>The global aim study improve current knowledge diabetic retinopathy ( DR ) progression . We aim characterize functionally morphologically initial DR stage identify patient risk progression centre involve macular oedema ( CME ) and/or proliferative diabetic retinopathy ( PDR ) . We want identify imaging pattern characteristic might use prognostic biomarkers DR progression . For , ischemia blood-retinal barrier alteration assess use non-invasive retinal imaging methodology . SD-OCT layer-by-layer segmentation perform . Furthermore , state-of-the-art methodology OCT-Angiography use identification area capillary drop-out leakage area identify SD-OCT without need dye injection . In subgroup patient study neurodegeneration pattern use multifocal ERG examination .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Type 2 diabetes mellitus accord 1985 WHO criteria Aged 35 year 80 baseline retrospective period NPDR level &lt; 20 ( MA absent ) Mild NPDR ( level 20 35 , base ETDRS criterion 7 field CFP ) baseline BCVA ≥ 75 letter ( ≥ 20/32 ) baseline ( ETDRS chart ) Informed Consent Inadequate ocular medium and/ pupil dilatation interfere fundus examination HbA1C &gt; 10 % Screening previous 6 month previous prospective study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>